生殖线和体质变异的整合改善慢性淋巴细胞白血病风险分层
Aubrey K Hubbard1, Derek W Brown2, Jie Liu3
1National Cancer Institute, Rockville, MD, United States.
Cancer research
|April 30, 2025
概括
整合遗传和血细胞数据可以改善慢性淋巴细胞白血病 (CLL) 风险预测. 结合生殖系遗传变异,多基因风险评分 (PGS) 和克隆性血液形成 (CH),可以更好地识别患有CLL高风险的人.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 癌症流行病学 癌症流行病学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 的风险受遗传遗传变异和获得突变的影响.
- 目前的CLL风险预测模型可以通过整合各种风险因素来改进.
研究的目的:
- 评估是否结合与CLL相关的多基因分数 (PGS) 和克隆性血液形成 (CH) 标记,特别是自体马赛克染色体变异 (mCA) 和不确定潜力的CH (CHIP),可以增强CLL风险分层.
- 评估结合生殖系,体和临床数据的综合模型的区分能力,以预测CLL风险.
主要方法:
- 分析了来自英国生物库的436,784名参与者和来自前列腺,肺部,结肠直肠和卵巢 (PLCO) 癌症查试验的35,382名参与者.
- 研究了特定的自身体mCA,淋巴细胞驱动基因中的CHIP突变和CLL风险之间的关联.
- 开发了结合性模型,包括性别,年龄,吸烟状况,血细胞特征,遗传相似性,CLL PGS,自体mCA和CHIP.
主要成果:
- 个别的mCA和CHIP突变与CLL风险有显著的关联.
- 结合了CLL PGS和CH的综合模型显示了CLL风险分层的最高分辨能力.
- 测量后大约五年,CH的预测效用下降了.
- 灵敏度分析证实了持续增加的辨别能力,即使在排除了异常血细胞计数或CH的人.
结论:
- 将生殖系遗传数据 (PGS) 与体质数据 (CH) 整合起来,可显著提高识别患有CLL高风险个体的能力.
- 对遗传倾向和克隆性血液形成的综合评估为CLL风险提供了增强的分层.
- 周围血液数据,包括生殖线和体质信息,对于高级CLL风险识别至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Lineage Commitment
2.9K
Commitment is the process whereby stem cells:
2.9K
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Mismatch Repair
4.6K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.6K


